Skip to content

Drug interactions

Dihydroergotamine + Rizatriptan

Severity: Contraindicated

Dihydroergotamine and Rizatriptan: contraindicated interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Rizatriptan and dihydroergotamine are both vasoconstrictors, and combined use may cause prolonged vasospasm. Risks include myocardial, cerebral and peripheral ischemia.

What this interaction means in plain words

Dihydroergotamine and Rizatriptan are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two.

Dihydroergotamine belongs to Central Nervous System; Rizatriptan belongs to Central Nervous System.

Evidence level: High

Why it happens

Additive vasoconstriction via 5-HT1B/1D agonism and ergot vascular receptor effects.

What to do

Avoid concurrent use and leave at least 24 hours between doses. Use only one agent per attack.

What to ask your pharmacist

  • Is there an alternative to one of these two medicines for me?
  • If both are essential, who is monitoring me and how often?
  • Which symptoms mean I should stop and seek help straight away?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Dihydroergotamine and Rizatriptan, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Dihydroergotamine with Rizatriptan?

MediHelp rates the interaction as contraindicated. Dihydroergotamine and Rizatriptan are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two. Rizatriptan and dihydroergotamine are both vasoconstrictors, and combined use may cause prolonged vasospasm. Risks include myocardial, cerebral and peripheral ischemia.

How serious is the interaction between Dihydroergotamine and Rizatriptan?

MediHelp rates it contraindicated, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid concurrent use and leave at least 24 hours between doses. Use only one agent per attack.

What other medicines interact with Rizatriptan?

MediHelp also lists interactions of Rizatriptan with, for example, Almotriptan, Dihydroergotamine intranasal, Eletriptan. The full list is on the Rizatriptan page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in